 Home > Medical News > Latest Medical News > Drugs that face an important review decision by the US FDA in August 2021!

Drugs that face an important review decision by the US FDA in August 2021!

 Last Update: 2021-08-04
 Source: Internet
 Author: User

Tags

review 2

collagen type 2

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Compilenewborn

Since the beginning of this year, the U.
S.
FDA has approved a total of 31 innovative drugs, and 4 (Kerendia, fexinidazole, Rezurock, Bylvay) were approved in July, of which:

-Sanofi fexinidazole is the first full oral treatment for the 2 disease stages of Trypanosoma brucei gambia sleeping sickness;

——Alberio's ileal bile acid transporter (IBAT) inhibitor Bylvay is the first drug to treat all subtypes of progressive familial intrahepatic cholestasis (PFIC);

——Bayer Kerendia is the first non-steroidal selective mineralocorticoid receptor antagonist (MRA) that significantly delays the progression of chronic kidney disease and reduces cardiovascular risk in patients with chronic kidney disease and type 2 diabetes;

-Kadmon's ROCK2 inhibitor Rezurock is the first treatment drug for patients with chronic graft-versus-host disease (GVHD) who have failed multiple alternative treatment options
.

Entering August, a number of drugs will usher in an important review decision by the FDA
.

The following is a brief summary of these drugs

Reference source: Biotech Stocks Facing FDA Decision In August 2021

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.